{
    "eid": "2-s2.0-85101473819",
    "title": "Early detection of neutralizing antibodies against SARS-CoV-2 in COVID-19 patients in Thailand",
    "cover-date": "2021-02-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Opass Putcharoen",
        "Supaporn Wacharapluesadee",
        "Wan Ni Chia",
        "Leilani Paitoonpong",
        "Chee Wah Tan",
        "Gompol Suwanpimolkul",
        "Watsamon Jantarabenjakul",
        "Chanida Ruchisrisarod",
        "Phanni Wanthong",
        "Jiratchaya Sophonphan",
        "Pajaree Chariyavilaskul",
        "Lin Fa Wang",
        "Thiravat Hemachudha"
    ],
    "citedby-count": 15,
    "ref-count": 23,
    "ref-list": [
        "Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review",
        "Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019",
        "Developing antibody tests for SARS-CoV-2",
        "The Role of Antibody Testing for SARS-CoV-2: Is There One?",
        "Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2",
        "The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times",
        "Bloom, Alexander, Greninger L. Neutralizing antibodies correlate with protection from SARS-1 CoV-2 in humans during a 2 fishery vessel outbreak with high attack rate",
        "A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction",
        "A new coronavirus associated with human respiratory disease in China",
        "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study",
        "Clinical Characteristics of Coronavirus Disease 2019 in China",
        "Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area",
        "Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections",
        "Differences in antibody kinetics and functionality between severe and mild SARS-CoV-2 infections",
        "Cochrane COVID-19 Diagnostic Test Accuracy Group. Antibody tests for identification of current and past infection with SARS-CoV-2",
        "Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates",
        "Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial",
        "Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate",
        "Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications",
        "Kinetics of viral load and antibody response in relation to COVID-19 severity",
        "Evaluation of serological tests for SARS-CoV-2: Implications for serology testing in a low-prevalence setting"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "60095034",
            "affilname": "Duke-NUS Medical School",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60095034",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60016965",
            "affilname": "The HIV Netherlands Australia Thailand Research Collaboration",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016965",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Biological Threat Reduction Program",
        "King Chulalongkorn Memorial Hospital\u2019s Excellence Centre Program",
        "US Defense Threat Reduction Agency",
        "NMRC"
    ]
}